Skip to main content

0800-CDCPL(23275)

Search for

Public Comments and CDC Response Papers

Public Comments and CDC Response Papers

Public Comments

CDC Notification No. Opening Date Closing Date Subject Status
02 of 2023 October 31, 2023 November 07, 2023 Proposed Amendments in the Schedule of Fees & Deposits Closed
01 of 2023 March 06, 2023 March 13, 2023 Proposed amendments in the CDC Regulations relating to Depository Receipt Closed
06 of 2022 August 30, 2022 September 06, 2022 Proposed amendments in the CDC Regulations relating to Various Matters Closed
05 of 2022 August 23, 2022 August 30, 2022 Proposed amendments in the Fees & Deposits of Schedule Closed
04 of 2022 June 01, 2022 June 08, 2022 Proposed amendments in the CDC Regulations relating to Introduction of the Centralized Gateway Portal Closed
03 of 2022 April 25, 2022 May 02, 2022 Proposed amendments in the CDC Regulations relating to Introduction of Savings Certificates and related matters Closed
02 of 2022 March 07, 2022 March 14, 2022 Amendments in the Schedule of Fees & Deposits Closed
01 of 2022 February 21, 2022 February 28, 2022 Proposed amendments in the CDC Regulations relating to Various Matters Closed
07 of 2021 September 10, 2021 September 17, 2021 Proposed Amendments in the Fees & Deposits Schedule Closed
06 of 2021 July 30, 2021 August 06, 2021 Proposed Amendments in the Fees & Deposits Schedules Closed
05 of 2021 June 17, 2021 June 24, 2021 Proposed amendments in the CDC Regulations relating to Shared KYC Information Closed
04 of 2021 May 04, 2021 May 11, 2021 Amendments in the Schedule of Fees for Investor Account Services Closed
03 of 2021 April 22, 2021 April 29, 2021 Proposed amendments in the CDC Regulations relating to Settlement of Listed Debt Securities by the Market Maker Closed
02 of 2021 March 26, 2021 April 02, 2021 Amendments in the Schedule of Fees & Deposits Closed
01 of 2021 March 11, 2021 March 18, 2021 Proposed amendments in the CDC Regulations relating to Various Matter Closed

  1. CDC invites the interested parties to provide their comments and views, with specific reference to the subject matter of the proposed amendments to CDC Regulations notified via notices, through any of the following modes.

Email

[email protected]

Mail

The Chief Compliance Officer,
Central Depository Company of Pakistan Limited
CDC House, 99-B, Block ‘B’,
S.M.C.H.S., Main Shahra-e-Faisal,
Karachi-74400, Pakistan

  1. At the time of submission of comments, respondent is advised to provide the information, as per Table-A below, so that CDC may contact him/her for clarification or deliberation on the comments, if needed. Anonymous responses may be disregarded by CDC.

Table A

To Be Filed By The Respondent

Name of respondent

 

Account No.

Name of company (if applicable)

 

Designation (if applicable)

 

Contact Number

 

Email Address

 
  1. The respondent may request confidential treatment for his/ her identity and all or any part of comments due to their proprietary, confidential or commercial nature, by clearly marking the information in Table-B below:

Table B

Disclosure of Identity and Comments

Please check the box(es) if you wish to be remain confidential:

    1. I wish to have my identity remain confidential.
    2. I wish to keep all or any part of my comments confidential.

If respondent wishes to keep any part(s) of comments confidential, then he/she is required to clearly specify such part(s) of comments.

  1. To ensure quality and promote transparency, CDC will publish the relevant comments of respondents and its management’s response thereon in the form of a Response Paper on its website, within a reasonable timeframe, after close of public consultation session, unless the respondent has made a confidentiality request.
  2. Any policy or rule amendment may be subject to regulatory concurrence. For this purpose, respondents should note that notwithstanding any confidentiality request, CDC will share all their response(s) with the Securities and Exchange Commission of Pakistan (Apex Regulator).
  3. By submitting comments, respondents are deemed to have consented to the collection, use and disclosure of data that is provided to CDC, unless respondents wish to have their identity or comments remain confidential.

Date